A biotech startup engaged in the research and commercialization of new materials. In addition to planning and developing over 200 CBD products, we have succeeded in research on nano CBD formulations that drastically improve CBD absorption efficiency, a first in the industry. In May 2022, we raised approximately ¥150 million in Series A funding. We have already distributed CBD products to over 500 locations nationwide, including medical institutions.
FACT BOX
- Source: PR TIMES
- Category: New Product
- Organizations: BOTANIQUE